The High Court has declined to review $280,000 in damages awarded to a lawyer, after an appeals court found a Today Tonight segment labelling her a “Centrelink cheat” was defamatory.
Qantas Airways will challenge a court’s finding that it incorrectly applied the JobKeeper scheme and underpaid its staff.
Queensland billionaire Clive Palmer has lost his bid to vacate a trial scheduled to start next week in a high-stakes lawsuit alleging he committed copyright infringement by using Twister Sister’s 1980s rock anthem ‘We’re Not Gonna Take It’ in campaign ads for his United Australia Party without a licence.
Financial crimes regulator AUSTRAC will not take legal action against Afterpay over its compliance with anti-money laundering laws, following an external auditor’s report that found the buy now, pay later provider had received “incorrect” legal advice from several top-tier law firms about its compliance program.
The Daily Mail has fired back at a defamation lawsuit by sports broadcaster Erin Molan alleging its coverage of a remark she made during Nine’s Continuous Call radio program implied she was a racist, telling the court that Molan has a history of “objectively racist” conduct on air.
The ACCC has taken a major wholesale supplier of sporting goods to court for allegedly setting minimum prices for cycling and sporting goods in its agreements with retailers.
Piper Alderman has struck back at a sex discrimination lawsuit brought by a former administrative assistant, admitting that while a law firm partner did tell her to “go spend time with your kids” following a meeting in which she was made redundant, the comment had been taken out of context.
Australia’s peak body representing legal professionals has called for more support for Federal Circuit and Family Court judges following the death of Judge Guy Andrew, telling Lawyerly that the “crippling pressures and workloads” faced by judges on the chronically underfunded courts created an unsafe workplace.
One of the lead applicants in a class action against ratings giant S&P Global, which is involved in a dispute with the funder that’s backing the case, wants to look at the funding agreement signed by the class action’s other lead applicant.
Pharmaceutical company Boehringer Ingelheim will take another crack at opposing a patent application for an injectable anti-parasite drug for livestock by a subsidiary of competitor Merck Sharp & Dohme.